Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis
Condition(s):Glomerulosclerosis, Focal SegmentalLast Updated:July 10, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Glomerulosclerosis, Focal SegmentalLast Updated:July 10, 2023Completed
Condition(s):Glomerulosclerosis, Focal SegmentalLast Updated:June 12, 2017Completed
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:September 16, 2021Terminated
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:July 29, 2022Completed
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:July 31, 2019Terminated
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:August 11, 2009Unknown status
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:December 5, 2023Recruiting
Condition(s):Primary Focal Segmental GlomerulosclerosisLast Updated:August 3, 2020Completed
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:March 8, 2023Recruiting
Condition(s):Focal Segmental Glomerulosclerosis (FSGS)Last Updated:July 12, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.